These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21552650)

  • 21. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
    J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis].
    Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):305-7. PubMed ID: 17711652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term (5- to 20-year) patency of the radial artery for coronary bypass grafting.
    Achouh P; Boutekadjirt R; Toledano D; Hammoudi N; Pagny JY; Goube P; Isselmou KO; Lancelin B; Fouquet R; Acar C
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):73-9, 79.e1-2. PubMed ID: 19944433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term follow-up use of "cypher" sirolimus-eluting stents in patients with coronary heart disease after coronary artery bypass grafting with occlusive lesions of the coronary artery].
    Savchenko AP; Akchurin RS; Rudenko BA; Shiriaev AA; Cherkavskaia OV; Kozlov GV
    Vestn Rentgenol Radiol; 2010; (4):4-12. PubMed ID: 22187903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Has the in situ right internal thoracic artery been overlooked? An angiographic study of the radial artery, internal thoracic arteries and saphenous vein graft patencies in symptomatic patients.
    Shah PJ; Bui K; Blackmore S; Gordon I; Hare DL; Fuller J; Seevanayagam S; Buxton BF
    Eur J Cardiothorac Surg; 2005 May; 27(5):870-5. PubMed ID: 15848328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of outcome after sirolimus-eluting stent implantation for complex in-stent restenosis.
    Migliorini A; Shehu M; Carrabba N; Giurlani L; Valenti R; Buonamici P; Dovellini EV; Parodi G; Antoniucci D
    Am J Cardiol; 2005 Oct; 96(8):1110-2. PubMed ID: 16214447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
    Mehilli J; Kastrati A; Byrne RA; Bruskina O; Iijima R; Schulz S; Pache J; Seyfarth M; Massberg S; Laugwitz KL; Dirschinger J; Schömig A;
    J Am Coll Cardiol; 2009 May; 53(19):1760-8. PubMed ID: 19422982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
    Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
    Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
    Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stenting of a stenotic radial artery coronary graft: a new therapeutic scenario in coronary artery disease.
    Patti G; Possati G; Di Sciascio G
    G Ital Cardiol; 1999 Feb; 29(2):149-51. PubMed ID: 10088070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry.
    Liistro F; Fineschi M; Angioli P; Sinicropi G; Falsini G; Gori T; Ducci K; Bravi A; Bolognese L
    J Am Coll Cardiol; 2006 Jul; 48(2):270-5. PubMed ID: 16843174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term outcome of patients with proximal left anterior descending coronary artery in-stent restenosis treated with rotational atherectomy.
    Moreno R; García E; Soriano J; Acosta J; Abeytua M
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):435-42. PubMed ID: 11285595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-eluting stent implantation for radial artery graft aorta-ostial stenosis.
    McKay E; Ramsdale KA; Ramsdale DR
    N Z Med J; 2008 May; 121(1273):66-8. PubMed ID: 18480888
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term clinical follow-up of sirolimus-eluting (CYPHER) coronary stents in the treatment of instent restenosis in an unselected population.
    Ruchin PE; Muller DW; Faddy SC; Baron DW; Roy PR; Wilson SH
    Heart Lung Circ; 2007 Dec; 16(6):440-6. PubMed ID: 17669686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation.
    Park SJ; Kim YH; Lee BK; Lee SW; Lee CW; Hong MK; Kim JJ; Mintz GS; Park SW
    J Am Coll Cardiol; 2005 Feb; 45(3):351-6. PubMed ID: 15680711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial.
    Park DW; Kim YH; Song HG; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Yun SC; Seung KB; Yang TH; Lee SG; Lee JH; Seong IW; Cheong SS; Lee BK; Lee NH; Lee SW; Lee SW; Lee K; Kim HS; Jeon DS; Kim MK; Nah DY; Tahk SJ; Park SJ
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1096-103. PubMed ID: 22017935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of sirolimus-eluting stent implantation for the treatment of ostial left anterior descending artery stenosis with intravascular ultrasound guidance.
    Seung KB; Kim YH; Park DW; Lee BK; Lee CW; Hong MK; Kim PJ; Chung WS; Tahk SJ; Park SW; Park SJ
    J Am Coll Cardiol; 2005 Sep; 46(5):787-92. PubMed ID: 16139126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.